CN115813822A - 一种高效祛痘组合物及其制备方法 - Google Patents
一种高效祛痘组合物及其制备方法 Download PDFInfo
- Publication number
- CN115813822A CN115813822A CN202211625333.4A CN202211625333A CN115813822A CN 115813822 A CN115813822 A CN 115813822A CN 202211625333 A CN202211625333 A CN 202211625333A CN 115813822 A CN115813822 A CN 115813822A
- Authority
- CN
- China
- Prior art keywords
- salicylic acid
- percent
- acne
- efficiency
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010000496 acne Diseases 0.000 title claims abstract description 76
- 208000002874 Acne Vulgaris Diseases 0.000 title claims abstract description 72
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title abstract description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical class OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 130
- 239000000284 extract Substances 0.000 claims abstract description 55
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 50
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 50
- 239000004721 Polyphenylene oxide Substances 0.000 claims abstract description 48
- 229920000570 polyether Polymers 0.000 claims abstract description 48
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 25
- CKZZREIPBTYJEQ-UHFFFAOYSA-N Totarol Natural products C1CC2C(C)(C)CCCC2(C)C2=C1C(C(C)C)=C(C)C=C2 CKZZREIPBTYJEQ-UHFFFAOYSA-N 0.000 claims abstract description 22
- ZRVDANDJSTYELM-FXAWDEMLSA-N totarol Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)C1=C2C(C(C)C)=C(O)C=C1 ZRVDANDJSTYELM-FXAWDEMLSA-N 0.000 claims abstract description 22
- 229940074347 totarol Drugs 0.000 claims abstract description 22
- ZRVDANDJSTYELM-UHFFFAOYSA-N trans-totarol Natural products C1CC2C(C)(C)CCCC2(C)C2=C1C(C(C)C)=C(O)C=C2 ZRVDANDJSTYELM-UHFFFAOYSA-N 0.000 claims abstract description 22
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 21
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 21
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 21
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 21
- -1 trisiloxane modified salicylic acid Chemical class 0.000 claims abstract description 17
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract description 16
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims abstract description 16
- 239000002904 solvent Substances 0.000 claims abstract description 16
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 16
- 239000000230 xanthan gum Substances 0.000 claims abstract description 16
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 16
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000405911 Rehmannia glutinosa Species 0.000 claims abstract description 15
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 claims abstract description 15
- 244000242564 Osmanthus fragrans Species 0.000 claims abstract description 13
- 235000019083 Osmanthus fragrans Nutrition 0.000 claims abstract description 13
- 229920001661 Chitosan Polymers 0.000 claims abstract description 8
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims abstract 3
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 claims description 28
- 238000003756 stirring Methods 0.000 claims description 21
- 235000019082 Osmanthus Nutrition 0.000 claims description 18
- 241000333181 Osmanthus Species 0.000 claims description 18
- 235000011187 glycerol Nutrition 0.000 claims description 15
- 241000405414 Rehmannia Species 0.000 claims description 12
- APZYKUZPJCQGPP-UHFFFAOYSA-N Tetrahydropiperine Chemical compound C=1C=C2OCOC2=CC=1CCCCC(=O)N1CCCCC1 APZYKUZPJCQGPP-UHFFFAOYSA-N 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 3
- 244000269722 Thea sinensis Species 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000002335 preservative effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 39
- 230000000638 stimulation Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 230000000844 anti-bacterial effect Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 9
- 230000003255 anti-acne Effects 0.000 description 7
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 6
- 239000011148 porous material Substances 0.000 description 6
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000012466 permeate Substances 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 3
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010037888 Rash pustular Diseases 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 208000031513 cyst Diseases 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 239000004519 grease Substances 0.000 description 3
- 229930007744 linalool Natural products 0.000 description 3
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 208000029561 pustule Diseases 0.000 description 3
- 210000002374 sebum Anatomy 0.000 description 3
- 231100000444 skin lesion Toxicity 0.000 description 3
- 206010040882 skin lesion Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000020154 Acnes Diseases 0.000 description 2
- 102000004363 Aquaporin 3 Human genes 0.000 description 2
- 108090000991 Aquaporin 3 Proteins 0.000 description 2
- 229920000832 Cutin Polymers 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 239000002390 adhesive tape Substances 0.000 description 2
- 239000003098 androgen Substances 0.000 description 2
- 229940030486 androgens Drugs 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 description 2
- 229940113120 dipropylene glycol Drugs 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229930015704 phenylpropanoid Natural products 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- PSQYTAPXSHCGMF-BQYQJAHWSA-N β-ionone Chemical compound CC(=O)\C=C\C1=C(C)CCCC1(C)C PSQYTAPXSHCGMF-BQYQJAHWSA-N 0.000 description 2
- SFEOKXHPFMOVRM-UHFFFAOYSA-N (+)-(S)-gamma-ionone Natural products CC(=O)C=CC1C(=C)CCCC1(C)C SFEOKXHPFMOVRM-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 241000186145 Corynebacterium ammoniagenes Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 244000148064 Enicostema verticillatum Species 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 206010027626 Milia Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 206010046865 Vaccinia virus infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000035 biogenic effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000011162 core material Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940092559 enterobacter aerogenes Drugs 0.000 description 1
- 125000003700 epoxy group Chemical group 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 235000021588 free fatty acids Nutrition 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- SWGZAKPJNWCPRY-UHFFFAOYSA-N methyl-bis(trimethylsilyloxy)silicon Chemical compound C[Si](C)(C)O[Si](C)O[Si](C)(C)C SWGZAKPJNWCPRY-UHFFFAOYSA-N 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000001483 monosaccharide substituent group Chemical group 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940002713 osmanthus fragrans flower extract Drugs 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 1
- 230000036619 pore blockages Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 208000007089 vaccinia Diseases 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- KDSWDGKIENPKLB-QJDQKFITSA-N verbascoside Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC(=O)CCC=2C=C(O)C(O)=CC=2)[C@@H](CO)O[C@@H](OCCC=2C=C(O)C(O)=CC=2)[C@@H]1O KDSWDGKIENPKLB-QJDQKFITSA-N 0.000 description 1
- QFRYQWYZSQDFOS-UHFFFAOYSA-N verbascoside Natural products CC1OC(COC2C(O)C(COC3OC(C(O)C(O)C3O)C(=O)O)OC(Oc4cc(O)cc5OC(=CC(=O)c45)c6ccc(O)c(O)c6)C2O)C(O)C(O)C1O QFRYQWYZSQDFOS-UHFFFAOYSA-N 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211625333.4A CN115813822A (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211625333.4A CN115813822A (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115813822A true CN115813822A (zh) | 2023-03-21 |
Family
ID=85516381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211625333.4A Pending CN115813822A (zh) | 2022-12-16 | 2022-12-16 | 一种高效祛痘组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115813822A (zh) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020058695A1 (en) * | 2000-05-19 | 2002-05-16 | Muhammed Majeed | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
JP2009234993A (ja) * | 2008-03-27 | 2009-10-15 | Shiseido Co Ltd | サリチル酸又はサリチル酸誘導体を含有する油中水型乳化組成物 |
CN103585926A (zh) * | 2013-11-22 | 2014-02-19 | 东华大学 | 一种耐酸碱聚醚改性三硅氧烷表面活性剂及其制备和应用 |
CN107890457A (zh) * | 2017-12-11 | 2018-04-10 | 广州赛莱拉干细胞科技股份有限公司 | 一种含有桂花干细胞提取物的增强免疫力、保湿组合物及其制备方法 |
CN111072754A (zh) * | 2019-12-04 | 2020-04-28 | 常熟理工学院 | 一种三硅氧烷改性肌肽及其制备方法 |
CN111643402A (zh) * | 2020-06-04 | 2020-09-11 | 昆明滇本生物科技有限公司 | 一种含锯叶棕精油的祛痘组合物及其制备方法 |
CN113413356A (zh) * | 2021-05-07 | 2021-09-21 | 广州摩亚方舟贸易有限公司 | 一种基于桃拓酚的祛痘组合物及其制备方法 |
CN114053175A (zh) * | 2021-11-13 | 2022-02-18 | 厦门海尼生物科技有限公司 | 一种祛痘产品及其制备方法 |
-
2022
- 2022-12-16 CN CN202211625333.4A patent/CN115813822A/zh active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020058695A1 (en) * | 2000-05-19 | 2002-05-16 | Muhammed Majeed | Method of increased bioavailability of nutrients and pharmaceutical preparations with tetrahydropiperine and its analogues and derivatives |
JP2009234993A (ja) * | 2008-03-27 | 2009-10-15 | Shiseido Co Ltd | サリチル酸又はサリチル酸誘導体を含有する油中水型乳化組成物 |
CN103585926A (zh) * | 2013-11-22 | 2014-02-19 | 东华大学 | 一种耐酸碱聚醚改性三硅氧烷表面活性剂及其制备和应用 |
CN107890457A (zh) * | 2017-12-11 | 2018-04-10 | 广州赛莱拉干细胞科技股份有限公司 | 一种含有桂花干细胞提取物的增强免疫力、保湿组合物及其制备方法 |
CN111072754A (zh) * | 2019-12-04 | 2020-04-28 | 常熟理工学院 | 一种三硅氧烷改性肌肽及其制备方法 |
CN111643402A (zh) * | 2020-06-04 | 2020-09-11 | 昆明滇本生物科技有限公司 | 一种含锯叶棕精油的祛痘组合物及其制备方法 |
CN113413356A (zh) * | 2021-05-07 | 2021-09-21 | 广州摩亚方舟贸易有限公司 | 一种基于桃拓酚的祛痘组合物及其制备方法 |
CN114053175A (zh) * | 2021-11-13 | 2022-02-18 | 厦门海尼生物科技有限公司 | 一种祛痘产品及其制备方法 |
Non-Patent Citations (7)
Title |
---|
ANNA OLEJNIK等: "Silsesquioxanes in the Cosmetics Industry—Applications and Perspectives", MATERIALS, vol. 15, no. 3, 31 January 2022 (2022-01-31) * |
刘婷;刘芳;陈亮;余娟;龚盛昭;: "植物黄酮类化合物在化妆品功效应用中的研究进展", 广东化工, no. 09, 15 May 2020 (2020-05-15) * |
常思思;董银卯;祝钧;何聪芬;: "壳聚糖改性水杨酸的刺激性和美白功效研究", 香料香精化妆品, no. 04, 31 August 2010 (2010-08-31) * |
无: "为什么我强烈建议油皮的人一定要用水杨酸祛痘?", pages 1 - 3, Retrieved from the Internet <URL:https://www.zhihu.com/tardis/bd/art/564327836> * |
李小迪;: "协同增效抗痘系列化妆品配方开发", 香料香精化妆品, no. 03, 30 June 2007 (2007-06-30) * |
王建新: "化妆品植物原料大全", 30 June 2012, 中国纺织出版社, pages: 93 * |
苗宗成等: "基于环氧氯丙烷醚化改性水杨酸的功能材料的制备", 化工新型材料, vol. 42, no. 11, 15 November 2014 (2014-11-15) * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101064904B1 (ko) | 천연 추출물을 포함하는 여드름 개선용 화장료 조성물 | |
CN109998937B (zh) | 含有甘油葡糖苷(αGG)的系列化妆品及其制备方法 | |
KR101422830B1 (ko) | 피부 pH 조절 및 유지효과가 우수한 화장료 조성물 | |
CN111494282B (zh) | 一种退红抗炎控油祛痘组合物及其应用与含有该组合物的祛痘平衡精华乳 | |
JP2003012489A (ja) | ヒアルロニダーゼ活性阻害剤及び保湿化粧料 | |
WO2005009454A1 (ja) | 歯周病治療用及び/又は予防用組成物 | |
WO2005034894A1 (ja) | 育毛剤組成物 | |
WO2002076479A1 (en) | Composition for treating acne vulgaris and fabrication method | |
KR102443283B1 (ko) | 마이크로바이옴을 이용한 피부 장벽 개선 효과가 우수한 화장료 조성물 | |
KR101123653B1 (ko) | 여드름 개선을 위한 화장료 조성물 | |
CN112402308A (zh) | 一种多效舒缓保湿水及其制备方法 | |
CN115337211B (zh) | 一种温和低敏性保湿祛痘凝胶及其制备方法 | |
CN115813822A (zh) | 一种高效祛痘组合物及其制备方法 | |
JPH06336422A (ja) | 皮膚外用剤 | |
CN115429738A (zh) | 一种祛痘修护焕活精华液及其制备方法 | |
JP2009191019A (ja) | 皮膚若しくは毛髪用化粧料 | |
JP3002166B2 (ja) | 高品質木酢液原料の製造方法 | |
JPH11171784A (ja) | 皮膚外用剤 | |
KR19990039050A (ko) | 말벌 독 추출물을 함유하는 여드름 예방 및 치료제 | |
BRPI1101172A2 (pt) | composiÇço desodorante e antiperspirante, processo para produÇço de composiÇço desodorante e antiperspirante e mÉtodo para prevenÇço e/ou reduÇço dos odores da transpiraÇço | |
KR101363028B1 (ko) | 레몬밤, 베르가못, 박하잎, 한련초 및 지구자 추출물을 유효성분으로 함유하는 여드름 예방, 개선 또는 치료용 화장용 조성물 | |
WO2007144723A2 (en) | Use of plants of carpobrotus edulis as anti-itching and/or anti-inflammatory agents | |
KR100331675B1 (ko) | 피부외용제 | |
KR102453167B1 (ko) | 식물성 세라마이드 성분을 함유하는 피부개선용 화장료 조성물 | |
JP2004175688A (ja) | 美白剤及び化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240228 Address after: Room 404-4, No. 1134 Jimei North Avenue, Software Park Phase III, Xiamen Torch High tech Zone, Xiamen, Fujian Province, 361000 Applicant after: Xiamen Haini Xinchuang Biotechnology Co.,Ltd. Country or region after: China Address before: Room 401, 4th Floor, No. 316, Tongji South Road, Jimei District, Xiamen City, Fujian Province, 361000 Applicant before: XIAMEN HAINI BIO-TECH Co.,Ltd. Country or region before: China |
|
TA01 | Transfer of patent application right |